These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21824751)

  • 41. Aspergillus niger as a new allergic agent associated with bindis and its efficacy against homeopathic drugs.
    Shrivastava JN; Kumar A; Bhatnagar VP
    J Environ Biol; 2006 Oct; 27(4):705-7. PubMed ID: 17405335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of oral saperconazole in systemic murine aspergillosis.
    Hanson LH; Clemons KV; Denning DW; Stevens DA
    J Med Vet Mycol; 1995; 33(5):311-7. PubMed ID: 8544084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful boric acid treatment of Aspergillus niger infection in an exenterated orbit.
    Aviñó-Martínez JA; España-Gregori E; Peris-Martínez CP; Blanes M
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):79-81. PubMed ID: 18209660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute aortic occlusion with sudden paraplegia secondary to Aspergillus niger embolism from Aspergillus niger aortitis.
    Jamieson RW; Wallace WA; Din JN; Raza Z
    J Vasc Surg; 2011 Nov; 54(5):1472-4. PubMed ID: 21715126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug therapy of aspergillus otitis externa.
    Lopez L; Evens RP
    Otolaryngol Head Neck Surg (1979); 1980; 88(6):649-51. PubMed ID: 6451857
    [No Abstract]   [Full Text] [Related]  

  • 46. Non-toxic agarose/gelatin-based microencapsulation system containing gallic acid for antifungal application.
    Lam PL; Gambari R; Kok SH; Lam KH; Tang JC; Bian ZX; Lee KK; Chui CH
    Int J Mol Med; 2015 Feb; 35(2):503-10. PubMed ID: 25482299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Sensitive screening of antifungal compounds from acetone extracts of medicinal plants with a Bio-Cell Tracer].
    Iida Y; Yonemura H; Oh KB; Saito M; Matsuoka H
    Yakugaku Zasshi; 1999 Dec; 119(12):964-71. PubMed ID: 10630102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosis.
    Singh S; Dabur R; Gatne MM; Singh B; Gupta S; Pawar S; Sharma SK; Sharma GL
    PLoS One; 2014; 9(8):e103039. PubMed ID: 25140804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic bilateral otomycosis caused by Aspergillus niger.
    Mishra GS; Mehta N; Pal M
    Mycoses; 2004 Feb; 47(1-2):82-4. PubMed ID: 14998406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ultrastructural study of the action of cyclosporine on cells of the fungus Aspergillus niger].
    Sazykin IuO; Zaslavskaia PL; Elkina ESh; Salova TV; Ivanov VP; Telesnina GN; Navashin SM
    Antibiot Khimioter; 1995; 40(11-12):34-9. PubMed ID: 8830638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 19-year-old male with a 3-day history of congestion and ear pain.
    Block TK; Munson E
    J Clin Microbiol; 2012 Jul; 50(7):2185, 2544. PubMed ID: 22711846
    [No Abstract]   [Full Text] [Related]  

  • 52. Fruit flies as a minihost model for studying drug activity and virulence in Aspergillus.
    Lionakis MS; Kontoyiannis DP
    Med Mycol; 2005 May; 43 Suppl 1():S111-4. PubMed ID: 16110801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Automatic evaluation of antifungal volatile compounds on the basis of the dynamic growth process of a single hypha.
    Oh K; Matsuoka H; Sumita O; Takatori K; Kurata H
    Appl Microbiol Biotechnol; 1993 Mar; 38(6):790-4. PubMed ID: 7763535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [2 cases of paranasal aspergilloma due to Aspergillus niger].
    Arnaud MV; Moraes MA; Nóbrega P
    Rev Soc Bras Med Trop; 1994; 27(1):43. PubMed ID: 8008920
    [No Abstract]   [Full Text] [Related]  

  • 55. Aspergillomycosis in intensively cultured tilapia from Kenya.
    Olufemi BE; Agius C; Roberts RJ
    Vet Rec; 1983 Feb; 112(9):203-4. PubMed ID: 6404044
    [No Abstract]   [Full Text] [Related]  

  • 56. Selective action of mycobacillin on the cellular permeability of Aspergillus niger.
    Das SK; Majumdar S; Basu S; Mukherjee S; Bose SK
    J Antibiot (Tokyo); 1986 Apr; 39(4):581-8. PubMed ID: 3710916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspergillus niger associated with mycotic abortion in a buffalo (Bubalus bubalis).
    Pal M
    Mycoses; 1988 Jan; 31(1):17-9. PubMed ID: 3374522
    [No Abstract]   [Full Text] [Related]  

  • 58. Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
    Calvo E; Pastor FJ; Salas V; Mayayo E; Guarro J
    Mycopathologia; 2012 Apr; 173(4):251-7. PubMed ID: 22139415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo.
    Calvo E; Pastor FJ; Mayayo E; Guarro J
    Int J Antimicrob Agents; 2011 Oct; 38(4):360-3. PubMed ID: 21824751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental efficacy of anidulafungin against Aspergillus terreus species complex.
    Sanchis M; Capilla J; Mayayo E; Pastor FJ; Guarro J
    Med Mycol; 2015 Aug; 53(6):630-5. PubMed ID: 25980004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.